Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1986 1
1987 3
1988 2
1989 2
1990 1
1991 1
1992 3
1993 1
1995 1
1996 9
1997 11
1998 4
1999 7
2000 12
2001 8
2002 11
2003 14
2004 20
2005 11
2006 21
2007 12
2008 16
2009 28
2010 29
2011 36
2012 44
2013 59
2014 81
2015 75
2016 76
2017 96
2018 89
2019 104
2020 127
2021 124
2022 190
2023 222
2024 96

Text availability

Article attribute

Article type

Publication date

Search Results

1,491 results

Results by year

Filters applied: . Clear all
Page 1
Redd1 knockdown prevents doxorubicin-induced cardiac senescence.
Huang P, Bai L, Liu L, Fu J, Wu K, Liu H, Liu Y, Qi B, Qi B. Huang P, et al. Among authors: qi b. Aging (Albany NY). 2021 May 6;13(10):13788-13806. doi: 10.18632/aging.202972. Epub 2021 May 6. Aging (Albany NY). 2021. PMID: 33962393 Free PMC article.
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer.
Adua SJ, Arnal-Estapé A, Zhao M, Qi B, Liu ZZ, Kravitz C, Hulme H, Strittmatter N, López-Giráldez F, Chande S, Albert AE, Melnick MA, Hu B, Politi K, Chiang V, Colclough N, Goodwin RJA, Cross D, Smith P, Nguyen DX. Adua SJ, et al. Among authors: qi b. Nat Commun. 2022 Dec 12;13(1):7690. doi: 10.1038/s41467-022-34889-z. Nat Commun. 2022. PMID: 36509758 Free PMC article.
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R, Liu YP, Xie YL, Lin C, Duan CY, Chen DP, Pan Y, Qi B, Zou X, Guo L, Cao JY, Zhang YN, Wang ZQ, Liu YL, Ouyang YF, Wen K, Yang Q, Xie RQ, Li HF, Duan XT, Ding X, Peng L, Chen SY, Liang JL, Feng ZK, Xia TL, Xie RL, Jiang R, Gu CM, Liu RZ, Sun R, Yang X, Liu LZ, Ling L, Liu Q, Ng WT, Hua YJ, Huang PY, Chen MY. You R, et al. Among authors: qi b. Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23. Lancet. 2023. PMID: 36842439 Clinical Trial.
A fully integrated wearable ultrasound system to monitor deep tissues in moving subjects.
Lin M, Zhang Z, Gao X, Bian Y, Wu RS, Park G, Lou Z, Zhang Z, Xu X, Chen X, Kang A, Yang X, Yue W, Yin L, Wang C, Qi B, Zhou S, Hu H, Huang H, Li M, Gu Y, Mu J, Yang A, Yaghi A, Chen Y, Lei Y, Lu C, Wang R, Wang J, Xiang S, Kistler EB, Vasconcelos N, Xu S. Lin M, et al. Among authors: qi b. Nat Biotechnol. 2024 Mar;42(3):448-457. doi: 10.1038/s41587-023-01800-0. Epub 2023 May 22. Nat Biotechnol. 2024. PMID: 37217752
1,491 results